Gong Y - Search Results

1

High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.

Yan T, Leng Y, Yang X, Gong Y, Sun H, Wang K, Xu W, Zheng Y, Naren D, Shi R. Yan T, et al. Among authors: gong y. Leuk Res. 2017 Jun;57:9-19. doi: 10.1016/j.leukres.2017.02.004. Epub 2017 Feb 16. Leuk Res. 2017. PMID: 28235656

2

Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.

Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y. Ye X, et al. Among authors: gong y. Leuk Res. 2009 Aug;33(8):1114-9. doi: 10.1016/j.leukres.2008.10.011. Epub 2008 Nov 26. Leuk Res. 2009. PMID: 19036441

3

[Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].

Zhou RQ, Gong YP, Zheng BH, Yang X. Zhou RQ, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;41(5):789-92. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21302442 Chinese.

4

[The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].

Yang X, Yang L, Gong YP, Chang H, Zhou RQ, Xing HY, Zheng BH. Yang X, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;41(5):793-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21302443 Chinese.

5

Antileukaemia effect of rapamycin alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukaemia cell line.

Yang X, Lin J, Gong Y, Ma H, Shuai X, Zhou R, Guo Y, Shan Q, He G. Yang X, et al. Among authors: gong y. Hematol Oncol. 2012 Sep;30(3):123-30. doi: 10.1002/hon.1013. Epub 2011 Sep 4. Hematol Oncol. 2012. PMID: 21898527

6

The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.

Xing H, Yang X, Liu T, Lin J, Chen X, Gong Y. Xing H, et al. Among authors: gong y. Leuk Res. 2012 Apr;36(4):509-13. doi: 10.1016/j.leukres.2011.12.018. Epub 2012 Jan 29. Leuk Res. 2012. PMID: 22285507

7

[Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].

Shan QQ, Gong YP, Guo Y, Lin J, Zhou RQ, Yang X. Shan QQ, et al. Among authors: gong yp. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 May;43(3):362-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22812238 Chinese.

8

Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.

Guo Y, Shan Q, Gong Y, Lin J, Yang X, Zhou R. Guo Y, et al. Among authors: gong y. Cancer Biol Ther. 2012 Nov;13(13):1244-54. doi: 10.4161/cbt.21460. Epub 2012 Aug 16. Cancer Biol Ther. 2012. PMID: 22895079 Free PMC article.

9

[Anti-leukemia effect of oridonin on Ph(+) acute lymphoblastic leukemia cell SUP-B15].

Guo Y, Shan QQ, Gong YP, Lin J, Yang X, Zhou RQ. Guo Y, et al. Among authors: gong yp. Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):439-43. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22967375 Chinese.

10

[The effect of knockdown of transcription factor SCL/TAL-1 gene on the erythroid differentiation in EPO-induced K562 cell line].

Zhou RQ, Gong YP, Guo Y, Shan QQ, Yang X. Zhou RQ, et al. Among authors: gong yp. Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):453-6. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22967379 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,541 results

Search Page

Filters